View Older Stories View More Recent Stories

Apr 15, 2021 07:39AM Form SC 13D Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 9, 2021 04:36PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Apr 8, 2021 06:01AM Form SC 13D Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 7, 2021 04:39PM Form SC 13D/A Turning Point Therapeuti Filed by: ORBIMED ADVISORS LLC
Mar 31, 2021 05:09PM Form 4 Oric Pharmaceuticals, For: Mar 29 Filed by: ORBIMED ADVISORS LLC
Mar 31, 2021 10:00AM Scribe Therapeutics Raises $100M Series B Financing to Further Develop “CRISPR by Design” Platform and Pipeline of Breakthrough Genetic Medicines
Mar 29, 2021 04:25PM Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Mar 29, 2021 07:30AM Crossover Health Secures $168 Million in Series D Financing to Fuel Expansion of National Primary Health Service
Mar 26, 2021 05:52PM Form 4 Oric Pharmaceuticals, For: Mar 24 Filed by: ORBIMED ADVISORS LLC
Mar 26, 2021 05:08PM Form SC 13D/A GRAYBUG VISION, INC. Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 09:40PM Form 3 Edgewise Therapeutics, For: Mar 25 Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 08:13PM Form 3 Ikena Oncology, Inc. For: Mar 25 Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 07:04PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Mar 24, 2021 12:00PM Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
Mar 23, 2021 05:23PM Form 4 Oric Pharmaceuticals, For: Mar 19 Filed by: ORBIMED ADVISORS LLC
Mar 22, 2021 04:00PM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
Mar 22, 2021 06:01AM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 18, 2021 09:08PM Form 4 Oric Pharmaceuticals, For: Mar 16 Filed by: ORBIMED ADVISORS LLC
Mar 15, 2021 08:56PM Form 4 Oric Pharmaceuticals, For: Mar 11 Filed by: ORBIMED ADVISORS LLC
Mar 4, 2021 07:30AM Syros Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
Mar 4, 2021 06:02AM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Mar 3, 2021 06:55PM Form 4 SpringWorks Therapeutics For: Mar 01 Filed by: ORBIMED ADVISORS LLC
Mar 3, 2021 04:01PM BlossomHill Therapeutics Closes $71M Series A Financing
Mar 3, 2021 04:01PM BlossomHill Therapeutics Closes $71M Series A Financing
Mar 3, 2021 11:10AM Best Penny Stocks To Buy After A Pullback? 3 To Watch Right Now
Mar 2, 2021 06:02AM Form SC 13G/A Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 2, 2021 06:01AM Form SC 13D Decibel Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 26, 2021 06:06AM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Feb 25, 2021 04:05PM Natera Reports Fourth Quarter and Year 2020 Financial Results
Feb 23, 2021 06:02AM Form SC 13D Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 22, 2021 03:48PM Form SC 13D Gemini Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 19, 2021 06:03AM Form SC 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 18, 2021 09:39PM Form 4 Adicet Bio, Inc. For: Feb 12 Filed by: ORBIMED ADVISORS LLC
Feb 17, 2021 05:09PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2021 05:22PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 12, 2021 05:18PM Form SC 13G/A Xenon Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:12PM Form SC 13G VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:11PM Form SC 13G Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:09PM Form SC 13G Strongbridge Biopharma Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:08PM Form SC 13G/A PROTHENA CORP PUBLIC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:07PM Form SC 13G OTONOMY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:05PM Form SC 13G/A ObsEva SA Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:02PM Form SC 13G Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:00PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:57PM Form SC 13G Larimar Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:56PM Form SC 13G/A Krystal Biotech, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:54PM Form SC 13G/A Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:53PM Form SC 13G/A Inspire Medical Systems, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:50PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:48PM Form SC 13G Forte Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories